Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Mayo Clinic

Status: Enrolling

Conditions: Bladder Urothelial Carcinoma

Treatments: Other: Non-Interventional Study

Study type: Observational

Funder types: Other

Identifiers

NCT07029256

NCI-2024-09054 (Registry Identifier)

23-008092 (Other Identifier)

Details and patient eligibility

About

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
• Prior abdominal imaging

Exclusion criteria

• History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

Trial design

100 participants in 1 patient group

Observational

Description:

Patients undergo standard of care radical cystectomy and residual tissues collected undergo US core needle biopsy. Additionally, patients have their medical records reviewed on study.

Treatment:

Other: Non-Interventional Study